Biomedical Engineering in New Jersey

📊 Employment Overview

New Jersey employs 513 biomedical engineering professionals, representing approximately 2.7% of the national workforce in this field. New Jersey ranks #11 nationally for biomedical engineering employment.

💰 Salary Information

Biomedical Engineering professionals in New Jersey earn competitive salaries across all experience levels, with an average annual salary of $112,000.

Note: Salaries are adjusted for cost of living and local market conditions. Data based on BLS statistics and industry surveys (2024-2025).

🎓 Schools Offering Biomedical Engineering

Loading school data...

🚀 Career Insights

Key information for biomedical engineering professionals in New Jersey.

🏢 Industry Landscape & Top Employers

New Jersey is one of America's most significant and often underappreciated biomedical engineering markets — ranking #11 nationally with 513 employed professionals and commanding a $112,000 average salary that reflects the state's extraordinary pharmaceutical and medical device industry concentration. The pharmaceutical capital of the world by virtually any measure, New Jersey hosts the global or North American headquarters of an astonishing number of the world's largest pharmaceutical and biotech companies, creating massive demand for drug delivery device engineers, combination product specialists, and pharmaceutical manufacturing systems engineers that is found nowhere else in the US at comparable scale.

Major Employers — Pharmaceutical Giants: Johnson & Johnson's worldwide headquarters (New Brunswick) encompasses multiple device divisions including DePuy Synthes (orthopedics), Ethicon (surgical devices), and Biosense Webster (cardiac mapping) that collectively make J&J one of the world's largest medical device employers, with significant New Jersey engineering operations. Merck & Company (Rahway) employs biomedical engineers in drug delivery device engineering and manufacturing systems. Becton Dickinson and Company (Franklin Lakes) — a global leader in syringes, infusion systems, and diagnostic instruments — maintains major NJ engineering and manufacturing operations. Integra LifeSciences (Princeton) develops neurosurgery and orthopedic devices. Novartis, Bristol-Myers Squibb, Regeneron, Otsuka, Daiichi Sankyo, Sanofi, and Boehringer Ingelheim all maintain major New Jersey R&D and engineering operations.

Combination Products — The NJ Specialty: New Jersey's defining biomedical engineering niche is the combination product — FDA-regulated products that combine a drug with a delivery device (auto-injectors, prefilled syringes, drug-eluting implants, inhalers). The engineering challenge of designing a device optimized for a specific pharmaceutical formulation, approved under both device and drug regulations, and manufactured at pharmaceutical-scale tolerances is uniquely concentrated in New Jersey's pharma corridor. Engineers with combination product expertise command premium compensation globally, and New Jersey is where this expertise is most densely concentrated in the world.

Key Industry Clusters: The Route 1 Corridor from Princeton through New Brunswick to the Raritan Valley is New Jersey's pharmaceutical engineering spine — Johnson & Johnson, Merck, Bristol-Myers Squibb, and dozens of pharma/biotech companies cluster along this axis. The Hudson County waterfront (Jersey City, Hoboken) houses corporate offices for global pharma companies whose operations are across the state, and provides easy Manhattan access for commercial and regulatory affairs engineers. Bergen County (Becton Dickinson in Franklin Lakes, Integra in Plainsboro) constitutes a north Jersey device corridor. The Princeton area hosts major pharma research campuses and a growing biotech ecosystem supported by Princeton University's life sciences programs.

📈 Career Growth & Pathways

New Jersey biomedical engineering careers are uniquely shaped by the pharmaceutical industry's influence — creating specializations in combination product engineering, pharmaceutical manufacturing systems, and drug delivery device design that represent some of the highest-compensated niches in all of biomedical engineering globally.

• Entry-Level Engineer (0–2 years): $69,000–$88,000 — J&J's structured engineering development programs, BD's new grad manufacturing and quality rotations, and Merck's device engineering associate roles are the most common entry points. Rutgers University's biomedical engineering program and Princeton University's engineering department are the primary New Jersey talent pipelines, supplemented by significant in-migration from Massachusetts and Pennsylvania.
• Mid-Level Engineer (3–7 years): $97,000–$130,000 — Device design ownership at J&J DePuy Synthes or Ethicon, combination product development at Merck or BMS, clinical technology leadership at RWJBarnabas Health or Hackensack Meridian Health, or regulatory affairs roles at J&J's worldwide regulatory affairs division in Raritan.
• Senior / Staff Engineer (8–14 years): $140,000–$180,000 — Technical lead on J&J next-generation surgical platforms, senior regulatory affairs engineer at a global pharma company's device division, clinical engineering director at a major NJ health system, or principal engineer at BD's NJ operations. Total compensation including pharma industry bonus structures can exceed $200,000 at this level.
• Principal / Director (15+ years): $175,000–$300,000+ — J&J sector engineering directors, global heads of device regulatory affairs at major pharma companies, research faculty at Rutgers or Princeton, or C-suite technology roles at NJ-based medical device companies. New Jersey's senior pharma-device engineers are among the most highly compensated biomedical engineering professionals in the world.

Combination Product Premium: Engineers who develop combination product expertise — FDA's regulatory pathway for drug-device combinations under 21 CFR Parts 3 and 4, design controls that satisfy both device QSR and pharma GMP requirements, and human factors engineering for complex delivery systems — command salary premiums of 25–45% above equivalent purely device or purely pharma engineers. New Jersey is the world's best location to develop these skills, and the expertise transfers to any pharmaceutical company globally.

💰 Salary vs. Cost of Living

New Jersey's $112,000 average biomedical engineering salary is among the highest in the nation — trailing only California and Massachusetts — and reflects the pharmaceutical industry's premium compensation structure. The state's cost of living is substantial, but the combination product salary premium and pharma industry bonus structures can make New Jersey financially competitive with lower-cost markets on a total-compensation basis.

Route 1 / Princeton Corridor: New Jersey's pharmaceutical engineering hub has significant cost pressures. Median home prices in Princeton ($700,000–$950,000+), Plainsboro ($480,000–$620,000), and New Brunswick (more affordable at $320,000–$420,000) reflect the area's premium employer density. Engineers earning $120,000–$165,000 at J&J or Merck face meaningful housing costs — though still substantially below the Manhattan and Brooklyn markets that the NJ-NYC ferry corridor engineers might otherwise consider. Princeton area cost of living is approximately 35–45% above the national average.

Bergen County / Franklin Lakes (BD Area): Northern New Jersey's cost pressure is significant — proximity to Manhattan drives housing prices in Bergen County to median levels of $550,000–$800,000 for single-family homes. BD's Franklin Lakes and Parsippany operations pay $100,000–$155,000 for experienced engineers, and the tri-state area lifestyle access (Manhattan restaurants, theater, airports) provides premium amenity access that partially justifies the cost premium.

Rutgers / Central NJ Corridor: Somewhat more affordable than the Princeton or Bergen County submarkets. Piscataway, Somerset, and Bridgewater communities offer median home prices of $380,000–$520,000 with reasonable commutes to the Route 1 pharma corridor. For engineers focused on the financial equation, central New Jersey's balance of pharma employer access and more moderate housing costs is the state's most financially defensible submarket.

New Jersey's Tax Burden: New Jersey's income tax (graduated rates up to 10.75% — among the nation's highest) and property taxes (the highest in the nation by many measures, averaging $9,000–$12,000+ annually for a median home) represent a significant financial consideration. After taxes and housing costs, New Jersey's net financial advantage over lower-cost states is substantially compressed. Engineers should carefully model after-tax, after-housing financial outcomes when comparing New Jersey to Indiana's Warsaw corridor or Illinois's North Shore for equivalent device career access.

📜 Licensing & Professional Development

Engineering licensure in New Jersey is administered by the State Board of Professional Engineers and Land Surveyors. New Jersey's dense professional engineering community and active licensing board make it one of the more rigorous licensing environments in the Northeast, with full NCEES reciprocity for the significant cross-border practice activity with New York and Pennsylvania.

New Jersey PE Licensure Path:

• FE Exam: Required first step. Rutgers, Princeton, Stevens Institute of Technology (Hoboken), and NJIT are New Jersey's major engineering schools. New Jersey also benefits from proximity to Penn, Drexel, and Temple for nearby engineering education.
• 4 Years of Progressive Experience: Under PE supervision. New Jersey's density of licensed engineers at major pharma and device companies makes finding supervising PEs straightforward.
• PE Exam: Full NCEES reciprocity. Tri-state PE licensing (NJ, NY, PA) is common practice for New Jersey engineers serving the greater NYC metro engineering market.

FDA Combination Product Regulatory Mastery: New Jersey's defining professional credential ecosystem centers on combination product regulatory expertise. RAPS RAC-US certification, combined with FDA Office of Combination Products (OCP) policy knowledge (21 CFR Part 3 — jurisdiction determination; FDA's combination product guidance documents), positions engineers for the state's highest-value roles. New Jersey's RAPS chapter is one of the nation's most active, with regular pharma-device intersection programming specifically tailored to the state's combination product engineering community.

Pharma Manufacturing Systems (GMP / EMA / ICH): For engineers at New Jersey's pharmaceutical manufacturing facilities, ICH Q8/Q9/Q10 quality systems knowledge, FDA cGMP (21 CFR Parts 210/211) expertise, and EU GMP Annex 1 compliance for aseptic processing are the dominant professional development priorities. ASQ's Certified Quality Engineer (CQE) and Certified Pharmaceutical Industry professional credentials are widely held by New Jersey's pharmaceutical manufacturing engineers.

CCE / CBET: RWJBarnabas Health — New Jersey's largest academic health system, affiliated with Rutgers University — and Hackensack Meridian Health both maintain sophisticated clinical engineering departments that value AAMI credentials. New Jersey's clinical engineering community participates in ACCE's Mid-Atlantic regional network alongside Maryland and Pennsylvania peers.

📊 Job Market Outlook

New Jersey's biomedical engineering market is positioned for sustained growth, anchored by the pharmaceutical industry's perpetual pipeline of combination product innovations, the ongoing expansion of New Jersey's academic medical centers, and the state's emerging biotech venture ecosystem that is beginning to complement its established corporate pharmaceutical heritage.

GLP-1 and Obesity Medicine Combination Products: The extraordinary commercial success of GLP-1 agonist therapies (semaglutide, tirzepatide, and next-generation compounds) is driving massive investment in drug delivery device engineering. New Jersey pharmaceutical companies are developing next-generation auto-injectors, implantable delivery systems, and oral formulation devices for these drugs — creating sustained demand for combination product engineers at the intersection of pharmaceutical formulation and medical device design. This is New Jersey's most significant near-term growth driver for biomedical engineering employment.

Oncology and Immunology Device Convergence: New Jersey's oncology and immunology pharmaceutical pipelines (J&J, Merck, BMS, Novartis) are generating increasingly complex drug delivery requirements — implantable drug depots, cell therapy manufacturing devices, and targeted delivery systems — that require sophisticated device engineering alongside pharmaceutical development. These programs are creating engineering roles at the frontier of biomedical knowledge that will sustain New Jersey's position as a global combination product engineering hub.

New Jersey Life Sciences Venture Ecosystem: New Jersey's life sciences venture capital community — anchored by pharma company spinouts, Princeton University commercialization, and Rutgers' growing innovation programs — is maturing. Several NJ-based biomedical device startups have emerged from this ecosystem in recent years, beginning to create the early-stage company engineering career tracks that New Jersey's market has historically lacked relative to Boston and San Francisco.

5-Year Projection: New Jersey biomedical engineering employment is projected to grow 12–17% over five years — driven by combination product pipeline expansion and NJ's maturing venture ecosystem. Total employment could approach 585–600 by 2029.

🕐 Day in the Life

Biomedical engineering in New Jersey operates at the intersection of pharmaceutical science and medical device engineering — a daily experience shaped by the discipline of pharmaceutical regulatory compliance, the innovation intensity of global R&D programs, and the unique professional culture of an industry that measures success in patient outcomes for diseases affecting hundreds of millions worldwide.

At Johnson & Johnson (New Brunswick / Raritan): Engineers at J&J's worldwide device operations work within one of the world's most sophisticated medical technology development organizations. A day at DePuy Synthes might involve a design review for a next-generation robotic total knee system — reviewing kinematic simulation data with the surgical robotics team, assessing manufacturing feasibility with the operations engineering team in Cork, and coordinating with J&J's worldwide regulatory affairs division on global submission strategy. The scale of J&J's operations means that engineers regularly engage with teams in Belgium, India, Brazil, and Japan — creating a genuinely global professional experience from a New Jersey suburban campus. The culture is process-disciplined, quality-obsessed, and shaped by J&J's Credo — the company's foundational statement of responsibility to patients, employees, and communities that is treated with genuine reverence rather than corporate formality.

At Becton Dickinson (Franklin Lakes): BD's NJ operations focus on injection systems, infusion therapy, and diagnostic pre-analytics — high-volume products where manufacturing precision, quality systems, and customer use considerations dominate engineering priorities. A day might involve reviewing injection force specification data for a new insulin pen device, coordinating with the human factors team on a user study protocol for a self-injection system for a biologic drug, and preparing technical documentation for an FDA combination product designation request. BD's culture is methodical, customer-focused, and reflective of a company that has been making injection systems since 1897 — institutional knowledge runs deep.

Lifestyle: New Jersey's lifestyle benefits are real but require navigating the state's complexity. The Route 1 corridor communities — Princeton, Plainsboro, Lawrenceville — offer genuine small-town character alongside world-class academic and cultural resources. Princeton University's campus (open to the community), McCarter Theatre, and the Princeton Art Museum provide cultural richness that surprises those who imagine New Jersey as purely industrial. The Jersey Shore's 130 miles of barrier island beaches are accessible for weekend escapes from the pharma corridor. New York City's unmatched cultural resources are 45–90 minutes away by transit. The challenge is cost: New Jersey's property taxes, cost of living, and the psychological weight of the commute culture (many NJ engineers commute into Manhattan for meetings) create a professional life that requires deliberate management to remain enjoyable. Engineers who embrace the state's suburban advantages, manage their commute carefully, and invest in the genuinely strong communities of central New Jersey find it a rewarding long-term home.

🔄 Compare with Other States

See how New Jersey compares to other top states for biomedical engineering: